Dova Pharmaceuticals, a subsidiary of Swedish Orphan Biovitrum AB (Sobi)
Overview
Dova Pharmaceuticals is a subsidiary of Swedish Orphan Biovitrum AB (Sobi) focused on the development and commercialization of treatments for rare diseases. As part of Sobi, Dova Pharmaceuticals contributes to the company's mission of providing innovative therapies for those with rare conditions.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Dova Pharmaceuticals, a subsidiary of Swedish Orphan Biovitrum AB (Sobi) in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.